BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2010
View Archived Issues
Taisho identifies novel MCH1 receptor antagonists
Read More
Merck Serono claims novel PI3K inhibitors
Read More
Novel antibacterial agents identified by AstraZeneca
Read More
AstraZeneca discloses novel Janus kinase inhibitors
Read More
Clinical data support safety and efficacy of BI-207127 plus PEG-IFN/RBV in HCV genotype 1
Read More
Merck & Co. presents new CETP inhibitor prodrugs for hypercholesterolemia
Read More
Cempra presents preclinical and clinical phase I data on CEM-101 antibiotic
Read More
Roche discloses R&D highlights of the first quarter of 2010
Read More
BAL-30072 active against beta-lactamase-producing enterobacteria in vivo
Read More
Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy
Read More
Lipocine earns milestone payment from Abbott for oral testosterone product
Read More
Tanezumab shows benefit in patients with interstitial cystitis
Read More
Tacrolimus improves symptoms of bladder pain syndrome/interstitial cystitis
Read More
Advanced Life Sciences reports preclinical data on Restanza as a biodefense countermeasure
Read More
Actelion launches epoprostenol for injection
Read More
Dainippon Sumitomo set to launch Metgluco in Japan
Read More
Abbott acquires Facet Biotech
Read More
Genmab begins new next-generation antibody program HuMax-cMet
Read More
Delcath reports phase III data on Delcath PHP System-delivered melphalan
Read More
Taiho launches 5-HT3 receptor antagonist Aloxi in Japan
Read More
Micromet achieves milestone under collaboration with Bayer Schering
Read More
Nuon advances NU-1618 to phase IIb for chronic hyperuricemia in gout
Read More
Morria Biopharmaceuticals to begin phase II trial of MRX-6
Read More
ImmunoCellular Therapeutics and University of Pennsylvania enter research agreement for ICT-107
Read More
ImmuneRegen and MPI Research to collaborate on development Homspera
Read More
Amylin, Lilly and Alkermes reply to FDA's complete response letter on Bydureon
Read More